Your browser doesn't support javascript.
loading
Peripheral lymphocyte signaling pathway deficiencies predict treatment response in first-onset drug-naïve schizophrenia.
Lago, Santiago G; Tomasik, Jakub; van Rees, Geertje F; Rustogi, Nitin; Vázquez-Bourgon, Javier; Papiol, Sergi; Suarez-Pinilla, Paula; Crespo-Facorro, Benedicto; Bahn, Sabine.
Afiliação
  • Lago SG; Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, United Kingdom.
  • Tomasik J; Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, United Kingdom.
  • van Rees GF; Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, United Kingdom.
  • Rustogi N; Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, United Kingdom.
  • Vázquez-Bourgon J; Department of Psychiatry, Marqués de Valdecilla University Hospital, IDIVAL, School of Medicine, University of Cantabria, Santander, Spain; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Santander, Spain.
  • Papiol S; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Barcelona, Spain; Institute of Psychiatric Phenomics and Genomics, University Hospital, Ludwig Maximilian University, Munich, Germany; Department of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilian University, M
  • Suarez-Pinilla P; Department of Psychiatry, Marqués de Valdecilla University Hospital, IDIVAL, School of Medicine, University of Cantabria, Santander, Spain; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Santander, Spain.
  • Crespo-Facorro B; Department of Psychiatry, Marqués de Valdecilla University Hospital, IDIVAL, School of Medicine, University of Cantabria, Santander, Spain; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Santander, Spain; Department of Psychiatry, School of Medicine, University Hospital Virgen
  • Bahn S; Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, United Kingdom. Electronic address: sb209@cam.ac.uk.
Brain Behav Immun ; 103: 37-49, 2022 07.
Article em En | MEDLINE | ID: mdl-35381347
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Esquizofrenia / Antipsicóticos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Brain Behav Immun Assunto da revista: ALERGIA E IMUNOLOGIA / CEREBRO / PSICOFISIOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Esquizofrenia / Antipsicóticos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Brain Behav Immun Assunto da revista: ALERGIA E IMUNOLOGIA / CEREBRO / PSICOFISIOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido